| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/25/2004 | EP1448089A2 Devices and methods for the restoration of a spinal disc |
| 08/25/2004 | EP1448056A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/25/2004 | EP1448053A2 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
| 08/25/2004 | EP1448051A2 Methods and formulations for minimizing spasticity in blood vessel grafts |
| 08/25/2004 | EP1347963B1 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors |
| 08/25/2004 | EP1343764B1 Urea and urethane derivatives as integrin inhibitors |
| 08/25/2004 | EP1278728B1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 08/25/2004 | EP1228235B1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/25/2004 | EP1212067A4 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 08/25/2004 | EP1177157A4 A vital matter and a producing method |
| 08/25/2004 | EP1156044B1 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both |
| 08/25/2004 | EP1150977B1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
| 08/25/2004 | EP1087963B1 Inhibitors of glycogen synthase kinase 3 |
| 08/25/2004 | EP1084270B1 Methods for assaying clotting in plasma |
| 08/25/2004 | EP1083903B1 Bridged indenopyrrolocarbazoles |
| 08/25/2004 | EP1082138B1 Texaphyrin conjugates and uses thereof |
| 08/25/2004 | EP1064018B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 08/25/2004 | EP0973769B1 Process for preparing eprosartan |
| 08/25/2004 | EP0973743B1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
| 08/25/2004 | EP0883616B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/25/2004 | EP0852463A4 Myogenic differentiation of human mesenchymal stem cells |
| 08/25/2004 | EP0830130B1 Tnf-alpha converting enzyme |
| 08/25/2004 | CN1524082A Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl idase inhibitors for the treatment or prevention of diabetes |
| 08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1524078A Antagonists of mcp-1 function and methods of use thereof |
| 08/25/2004 | CN1524077A Therapeutic chroman compounds |
| 08/25/2004 | CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 08/25/2004 | CN1524003A Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 08/25/2004 | CN1523998A Sustained-release compositions for injection and process for producing the same |
| 08/25/2004 | CN1523997A Stabilized interleukin 2 |
| 08/25/2004 | CN1523991A Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1523988A Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 08/25/2004 | CN1523986A Substituted oxazolidinones for combinational therapy |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1523015A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/25/2004 | CN1522752A Animal brain extract and bitter gourd extract composition and its uses |
| 08/25/2004 | CN1522716A Use of compound red-rooted salvia drop pills in preparation of leucocyte adherence prohibiting drug |
| 08/25/2004 | CN1522715A Use of compound red-rooted salvia drop pills in preparation of vascular permeability resistant drug |
| 08/25/2004 | CN1522714A Use of compound red-rooted salvia drop pills in preparation of mass cell degranulation prohibiting drug |
| 08/25/2004 | CN1522713A Use of compound red-rooted salvia drop pills in preparation of albumin leakage prohibiting drug |
| 08/25/2004 | CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy |
| 08/25/2004 | CN1163599C Anti-GPIIB/IIIA recombination antibody |
| 08/25/2004 | CN1163486C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 08/25/2004 | CN1163484C 4-Aroyl-Piperidin-CCR-3 receptor antagonist III |
| 08/25/2004 | CN1163477C Substituted beta-alanine |
| 08/25/2004 | CN1163475C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivative and use as MEK inhibitor thereof |
| 08/25/2004 | CN1163466C Substituted oxobutyric acid derivative as matrix metalloprotease inhibitor |
| 08/25/2004 | CN1163246C Formula and process for preparing charred moxibustion stick |
| 08/24/2004 | US6780997 Such as dibenzyl(a,3-o-isopropylidiene-3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl) hydroxymethylphosphonate which functions like pyridoxal-5'-phosphate in vivo; drug screening; antidiabetic agents |
| 08/24/2004 | US6780996 Process for the preparation of 7-substituted-3 quinolinecarbonitriles |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780890 Contacting s-adenosylhomocysteine (sah with a luxs protein whereby s- adenosylhomocysteine undergoes conversion to autoinducer-2 |
| 08/24/2004 | US6780878 Antithrombotic amides |
| 08/24/2004 | US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent |
| 08/24/2004 | US6780873 Urea substituted imidazoquinolines |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780868 Treatment of myocardial or peripheral ischaemia, cardiac insufficiency or pulmonary arterial hypertension |
| 08/24/2004 | US6780867 Thienopyrimidines |
| 08/24/2004 | US6780866 Analgesic composition and method |
| 08/24/2004 | US6780864 Piperazine and piperidine compounds |
| 08/24/2004 | US6780862 Such as amino-indazoles for treatment of central nervous system disorders |
| 08/24/2004 | US6780861 Azabicyclic carbamates and their use as α-7 nicotinic acetylcholine receptor agonists |
| 08/24/2004 | US6780859 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders |
| 08/24/2004 | US6780855 Treating a patient suffering from an estrogen dependent-disease |
| 08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
| 08/24/2004 | US6780839 Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 08/24/2004 | US6780611 G protein coupled receptors; drug screening |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/24/2004 | US6780608 Comprises chimeric polypeptides with varying calcium/caffeine sensitivity; for drug screening |
| 08/24/2004 | US6780431 Substituted benzylthiazolidine-2,4-dione derivatives |
| 08/24/2004 | US6780429 With 2'-5' phosphodiester bond content up to 3%; maintains pharmacological action while reducing toxicity |
| 08/24/2004 | US6780427 Superoxide dismutase or other antioxidant are directly applied in combination with polymeric hydrogels at local sites of tissue injury to prevent or decrease formation of adhesions and undesirable proliferation of cells |
| 08/24/2004 | US6780400 Delivery of antiemetics through an inhalation route |
| 08/24/2004 | US6780399 Delivery of stimulants through an inhalation route |
| 08/24/2004 | CA2334415C Compositions for increasing energy in vivo |
| 08/24/2004 | CA2323213C Treatment of respiratory disease and otitis media |
| 08/24/2004 | CA2313122C Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents |
| 08/24/2004 | CA2293711C Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
| 08/24/2004 | CA2290252C Process and intermediates for growth hormone secretagogues |
| 08/24/2004 | CA2201784C Method and formulation of stimulating nitric oxide synthesis |
| 08/24/2004 | CA2143610C Use of norastemizole for the treatment of allergic disorders |
| 08/24/2004 | CA2061148C Glia activating factor and its production |
| 08/19/2004 | WO2004069999A2 Screening method |
| 08/19/2004 | WO2004069869A1 Apoptosis-inducing gene and utilization of the same |
| 08/19/2004 | WO2004069855A1 Novel glycosyl transferase with consideration of activity expression mechanism and method of producing the same |
| 08/19/2004 | WO2004069834A1 Tricyclic compound, process for producing the same, and use |
| 08/19/2004 | WO2004069833A1 Fused-ring pyridine derivative, process for producing the same, and use |
| 08/19/2004 | WO2004069828A1 Piperidine compound and medicinal use thereof |
| 08/19/2004 | WO2004069824A1 Pyrazole derivative |
| 08/19/2004 | WO2004069810A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | WO2004069809A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | WO2004069808A1 Acrylamide derivative, process for producing the same, and use |
| 08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | WO2004069788A1 Carboxylic acid compounds |
| 08/19/2004 | WO2004069276A1 Drug for preventing, regulating or treating adhesion |
| 08/19/2004 | WO2004069275A1 Ophthalmic drugs |
| 08/19/2004 | WO2004069268A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE |